Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats acne vulgaris. Sold as Epiduo, Epiduo Forte, Differin Epiduo, Differin Epiduo Acne Gel. Every FDA application for this active ingredient: 3 branded and 11 generic.
As of Nov 16, 2026, FDA lists 14 applications for Adapalene; Benzoyl Peroxide (sold as Epiduo, Epiduo Forte, Differin Epiduo and others), first approved Dec 8, 2008, with 1 new use approved and 0 published complete response letters.
First approved: Dec 8, 2008
Applications: 14
New uses approved: 1
Complete response letters: 0
Medicare spending, 2025: $204K
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Adapalene-Benzoyl Peroxide
Part D
$160K
-11%
1,034
Epiduo Forte
Part D
$44K
-28%
19
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
EPIDUO FORTE 0.3-2.5% GEL PUMP: $14.97 per GMBrand · +0% in a year
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA